Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
205 Results for "
immunogenic
" in MedChemExpress (MCE) Product Catalog:
Products (205)
205 Results for "immunogenic" in MCE Product Catalog:
Cat. No.: HY-160429
CAS No.: 2313534-26-6
Synonyms: Ac-PSAR18-COOH
Target:
Research Areas:
Cat. No.: HY-P6312
CAS No.: 183273-40-7
Target:
Research Areas:
Target:
Research Areas:
Poly-L-Glutamic acid (MW 700000) is a synthetic polypeptide with biocompatibility, biodegradability and non-immunogenicity. Poly-L-Glutamic acid is an ideal tumor-targeting polymer carrier. Poly-L-Glutamic acid can be hydrolyzed by cathepsin B during metabolic decomposition .
Cat. No.: HY-P3487
CAS No.: 1223335-84-9
Target:
Research Areas:
Cat. No.: HY-140692
Target:
Research Areas:
mPEG20000-Mal is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
Research Areas:
Lipid 14 is an ionizable amino lipid. Lipid 14 delivers mRNA into target cells, significantly enhancing the in vivo expression efficiency and immunogenicity of mRNA. Lipid 14 can be used to synthesize lipid nanoparticles (LNPs). Lipid 14 can be used for studies of SARS-CoV-2 and Yersinia pestis .
Cat. No.: HY-17663
CAS No.: 2992741-10-1
KMR-206 is a PARP7 inhibitor with an IC50 of 13.7 nM. KMR-206 relieves AHR-mediated transcriptional repression and enhances CYP1A1 expression in the presence of TCDD. KMR-206 induces the STING-dependent IFN-β signaling pathway and increases the levels of STAT1, pSTAT1 and nuclear PARP7 in cancer cells. KMR-206 reduces the viability of lung adenocarcinoma cells, enhances radiation-induced immunogenic signals, and induces the production of immunogenic signals in glioblastoma cancer stem cells. KMR-206 destabilizes FRA1 to increase IRF1 levels and promotes the IRF3-CBP/p300 interaction. KMR-206 can be used in studies related to lung adenocarcinoma and glioblastoma .
Cat. No.: HY-P9932
CAS No.: 1351337-07-9
Synonyms: ETI 204
Target:
Research Areas:
Synonyms: mPEG40000-SC; mPEG40000-Succinimidyl ester
Target:
Research Areas:
m-PEG-NHS ester (mPEG-SC; mPEG-Succinimidyl ester) (MW 40000) is a polyethylene glycol derivative. m-PEG-NHS ester serves as a modifying agent that reacts with free amino groups on the surface of protein or polypeptide molecules to form stable amide bonds, thereby covalently linking PEG chains to biomacromolecules, improving their antigenicity and immunogenicity, and facilitating the preparation of injectable formulations .
Cat. No.: HY-W596474D
CAS No.: 26247-79-0
Cat. No.: HY-140693
Purity: ≥98.0%
Target:
Research Areas:
m-PEG30000-mal is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
Cat. No.: HY-140721
Target:
Research Areas:
Mal-PEG5000-mal is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
Cat. No.: HY-W087907
CAS No.: 530-75-6
Target:
Research Areas:
Acetylsalicylsalicylic acid exhibits immunogenicity that induces contact sensitivity and causes skin erythema and slight edema in guinea pigs .
Cat. No.: HY-P3488
CAS No.: 2032119-68-7
Target:
Research Areas:
Cat. No.: HY-W587780
CAS No.: 29699-89-6
Synonyms: SMX-NO
Target:
Research Areas:
Sulfamethoxazole-NO (SMX-NO) is the major immunogen in sulfonamide allergy, producing modest ascorbic acid depletion and hemoglobin adduct formation. Sulfamethoxazole-NO haptens tissue proteins and is immunogenic in rodents .
Cat. No.: HY-W596474B
CAS No.: 26247-79-0
Cat. No.: HY-W596474C
CAS No.: 26247-79-0
Cat. No.: HY-140691
Purity: 99.89%
Target:
Research Areas:
mPEG10000-Mal is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
